✦ LIBER ✦

ADOPTIVE TRANSFER AND SPECIFIC ACTIVE IMMUNIZATION OF PATIENTS WITH MALIGNANT MELANOMA

✍ Scribed by H. F. Seigler; C. E. Buckley; L. B. Sheppard; B. J. Horne; W. W. Shingleton

Book ID: 114882487
Publisher: John Wiley and Sons
Year: 1976
Tongue: English
Weight: 526 KB
Volume: 277
Category: Article
ISSN: 0890-6564
DOI: 10.1111/j.1749-6632.1976.tb41726.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Active specific immunization in malignan

Active specific immunization in malignant melanoma

✍ Gercovich, Felipe G. ;Gutterman, Jordan U. ;Maviigit, Giora M. ;Hersh, Evan M. 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 640 KB

## Abstract The effects of active specific immunization with nonirradiated autologous and irradiated cultured allogeneic melanoma tumor cells (TC) on cell‐associated immunity was studied in 11 patients with widespread malignant melanoma receiving chemoimmunotherapy. Immunization with 1 × 10^6^‐8 ×

Tyrosinase activity in the sera of patie

Tyrosinase activity in the sera of patients with malignant melanoma: Method and specificity

✍ K. Nishioka; M. M. Romsdahl; H. A. Fritsche Jr.; M. J. McMurtrey 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 French ⚖ 411 KB

## Abstract Serum tyrosinase activity has been measured by adapting the [^3^]tyrosine assay for tyrosinase and significant elevations of serum tyrosinase activity were found in patients with malignant melanoma. In contrast to findings in a study which utilized [^14^C]tyrosine, augmented levels of t

Tumour regression and survival of patien

Tumour regression and survival of patients with disseminated malignant melanoma treated with chemotherapy and specific active immunotherapy

✍ D.W. Hedley; T.J. McElwain; G.A. Currie 📂 Article 📅 1977 🏛 Elsevier Science ⚖ 403 KB

Adoptive transfer of virus-specific and

Adoptive transfer of virus-specific and tumor-specific T cell immunity

✍ Carolina Berger; Cameron J Turtle; Michael C Jensen; Stanley R Riddell 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 349 KB

Immune responsiveness of patients with m

Immune responsiveness of patients with malignant melanoma and carcinoma of the breast

✍ Loren Humphrey; Om Singla Ms 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB

Lymphocyte blastogenesis (LB) with PHA, CON-A, PWM, V,, (homologous tumor extract) plus T/B ratio for pre-IT, post-IT (2 months), and 3, 6, 9, 12, 18, and 24 months prior to each V,, booster are reported. Pre-IT and post-IT LB-PHA were similar for Stage I (ST I) or Stage I1 (ST 11) breast cancer (BC

Cellular immunity in patients with malig

Cellular immunity in patients with malignant melanoma and their household contacts

✍ L. E. Spitler; F. N. Littooy; R. W. Sagebiel 📂 Article 📅 1977 🏛 Springer-Verlag 🌐 English ⚖ 719 KB